Full Text
Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia Gravis

Abstract

Authors

M. Georgieva S. Wheeler J.F. Howard Jr.

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×